Dizal (Jiangsu) Pharmaceutical Co. Ltd.SSE: 688192

(688192)"DIZAL PHARMACEUTICAL CO., LTD."Report for Q3 2026

· Issued by Dizal (Jiangsu) Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688192 · · 13 pages · Chinese

Summary by 6ix AI

The report confirms that the financial data has not been audited and emphasizes the accuracy and completeness of the information provided. The report also outlines ongoing research and development efforts, including advancements in cancer treatment drugs.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix

Earlier from Dizal (Jiangsu) Pharmaceutical

Later from Dizal (Jiangsu) Pharmaceutical

All Dizal (Jiangsu) Pharmaceutical news releases